Treatment of massively obese patients by extended or intermittent starvation has proved to be a relatively benign method for initiating weight reduction programs. Because the problem of obesity is chronic and discouraging, starvation has a certain appeal for many patients, and it has not been difficult to obtain volunteers for metabolic observations.
Intravenous glucose tolerance tests were done in six patients with 50 ml. of 50% glucose injected over two minutes. Serum uric acid was determined by the Caraway method,2 serum bicarbonate by a micromodification of the Peters and Van Slyke method,' and cholesterol by the Abell and Levy method. 4 Urinary excretion of 17-ketosteroids (17-KS) was determined by a modification of the Norymberski method.' Plasma 11-hydroxycorticoids were measured by the DeMoor method.8 Pulmonary function studies were done by the laboratory for the Pulmonary Disease Section. RESULTS Historically, three of the seven female patients had a family history of diabetes and four had a strong family history of massive obesity. Only one female patient in the group had a family history negative for both diabetes and obesity.
As others have noted,9-11 all patients tolerated the fast extremely well. One patient (C.G.) who had a history of striking hyperphagia, remained hungry throughout the fast, dreamed of food, and became somewhat depressed. She refused to abandon the fast in spite of her discomfort. All patients noted a bad taste in their mouths and complained of halitosis during the fast.
The physical characteristics of the group are listed in Table I . Although all the patients are unquestionably obese, they can be separated into two distinct groups. Four had "Cushingoid features" such as truncal fat distribution, moon facies, and dorsal cervical or supraclavicular fat pads, whereas the other four lacked these features and were generally obese. It was interesting that three of the four "Cushingoid" females had very irregular menstrual patterns whereas the three women with generalized obesity had completely normal menstrual cycles.
Weight loss
All eight patients lost weight during the study, although at varying rates (Table 2) . During the baseline period one patient on unrestricted salt intake remained stable, one had a slight gain, and a third lost 2.25 pounds. Four of five patients whose sodium intake was restricted lost weight during this phase.
During the fast all patients lost weight. Excluding patient P.C., who had a long, complicated pre-study course with intensive treatment for myxedema, respiratory acidosis, hypoventilation, and congestive heart failure, weight losses ranged from 12 to 20.8 pounds with an average for the seven patients of 15.4 pounds. On refeeding, only one patient (M.A.) actually gained weight. Two others (B.F. and C.M.) lost less than a pound in the six days, but the remaining patients lost from 1.4 4) o C>.S I S X z . UOd .
to 4.0 pounds in this period. During the entire study, excluding patient P.C., weight losses ranged from 16.0 to 28.5 pounds. When two patients with truncal obesity, plethora, dorsal cervical fat pads and striae (E.B. and C.G.), who had been restricted in sodium intake, were compared with two generally obese patients similarly restricted, there were no significant differences in weight loss during fasting.
Laboratory data
The six patients who had intravenous glucose tolerance tests had completely normal curves. The ketosis, acidosis and hyperuricemia previously described9" were found in all patients. Figure 1 represents the rise in uric acid that accompanied the acetonuria and the fall of serum bicarbonate after fasting in three patients. In the two in which it was measured, urate levels in the urine dropped as the serum uric acid levels became elevated. All these changes were promptly reversed by refeeding with a 500 calorie carbohydrate diet. We were interested in seeing whether the hyperuricemia could be reproduced by inducing acidosis by another mechanism. These three patients were then given 10 grams of NH4Cl a day. The serum bicarbonate fell to levels as low as those attained during fasting. However, the acidosis was unaccompanied by ketosis and there was no acetonuria and no elevation of the serum uric acid.
Serum cholesterol determinations during the three study periods are recorded in Table 3 . Only three patients had values over 200 mg./ml. in the baseline period. All but one (M.L.) rose slightly by the end of the fast and then dropped in the refeeding period. Fasting plasma 11-hydroxycorticoid levels were not abnormally elevated in any of the patients (Table 4 ). In one patient (E.B.) there was no significant diurnal variation, but we could not eliminate the possibility that stress had altered the pattern in this adolescent girl. In three patients (C.G., E.B. and P.C.) there was mild hyper-responsiveness to a 5-hour infusion with 40 units of ACTH. Morning plasma 1 1-hydroxycorticoid values at the end of the fast were determined in six of the eight patients. In four instances these determinations were lower than those of the baseline period. In two patients the values were higher after fasting, but still within the normal range. Table 5 shows the 24-hour urinary 17-ketosteroids and 17-ketogenic steroids in the baseline period, after 8 hours' stimulation with 40 units of ACTH intravenously, after fasting, and after three days of refeeding. Two patients with features suggesting endocrinopathy (C.G. and E.B.) had higher 17-KG levels after fasting than in the baseline period. Their 17-KG response to ACTH administration was also higher than normal, but baseline and refeeding levels were well within normal limits.
In the group with generalized obesity, the patient with post-surgical myxedema (P.C.) who had shown hyper-responsiveness of the plasma 11-hydroxycorticoids to ACTH also had an elevation of urinary 17-KG steroids on the fourth day of the fast as compared with baseline values. Patient S.G. had a minimal rise from 3.6 to 4.2 mg/24 hours.
After seven days' fasting the 17-ketosteroids were lower in six patients. No baseline determination was available in patient M.L. and the elevated value recorded for patient P.G. was on Day 4 of the fast.
Although two patients with features suggesting endocrinopathy had a paradoxical rise in 17-KG after fasting and ACTH administration, the two groups could not be clearly differentiated by this observation.
There was no consistent relationship of weight distribution or the historical or physical characteristics of the obesity to the adrenal findings in these eight patients.
Pulmonary function studies were done in seven of the patients. Only one subject (P.C.) had clinical or laboratory evidence of the hypoventilation syndrome, with somnolence, cyanosis, and arterial oxygen desaturation. Her situation was complicated by long-standing untreated myxedema and congestive heart failure. The six other patients studied had no evidence of hypoventilation despite their huge size, and three of them actually had a somewhat high alveolar ventilation. After the period of fasting four of the seven patients increased their maximum breathing capacities, which had been normal initially, and two patients showed no change. The seventh patient could not be studied after fasting.
The refeeding period
After the 7-day fast all eight patients had moderate anorexia. Several complained that they were unable to eat the 500 calorie refeeding diet.
Five of the seven patients (excluding P.C.) were refed with a 500 calorie carbohydrate diet. They ended the period with weight losses varying from 0.25 to The sixth patient (M.A.) was refed with 525 calories and an unlimited salt intake, with 40 grams of carbohydrate, 35 grams of protein and 25 grams of fat. She gained 3.75 pounds in the 6-day refeeding period. The seventh patient was refed with 500 calories of protein and lost four pounds during the first six days after the fast. The daily weights during the first six days of refeeding for all the patients except P.C. are plotted in Figure 2 .
The metabolic acidosis, ketonuria and hyperuricemia induced by fasting were quickly reversed by refeeding.
Daily 24-hour urinary sodium determinations were obtained throughout the study. periods of the study in four patients receiving 200-500 mg. sodium, with that in three subjects on an unrestricted sodium intake. In both groups sodium continued to be excreted during the fast, but with refeeding there was a striking fall in sodium excretion regardless of whether the diet was limited to carbohydrate, exclusively protein, or balanced with carbohydrate, protein, and fat. In the four patients who had been on a 200-500 mg. sodium baseline diet before the fast, urinary sodium excretion dropped to less than 1 mEq/24 hours throughout the 6-day refeeding period.
Figure 4 depicts weight losses and sodium excretion in three patients who had differences in sodium intake or dietary composition but not in total calories. When sodium was unrestricted (M.A.) no weight loss occurred on a baseline 2,400 calorie diet; 13.75 pounds were lost during fasting and there was a weight gain of 3.75 pounds on refeeding with only 500 calories of carbohydrate. Patient E.B., who had a sodium-restricted diet, lost 8.5 pounds in the baseline period, 12 pounds during the fast and 1.4 pounds on carbohydrate refeeding. Patient C.G. lost 10.75 pounds in the baseline period with sodium restriction, 13.75 pounds during the fast and on refeeding with 500 calories of protein lost an additional four pounds in six days. All three patients excreted less than 4 mEq/L of sodium in daily 24-hour urine collections during six days of refeeding.
Daily urinary ammonia excretions were determined in five patients. There was a marked increase in ammonia output from baseline levels of 
DISCUSSION
This study has reported preliminary observations made on eight massively obese patients during a baseline period, starvation for seven days, and refeeding. Although four of the patients had clinical features slightly suggestive of endocrine disease, we were unable to identify any consistent abnormalities in adrenal function or metabolic response to starvation that would be helpful in devising a more meaningful obesity classification.
Certain aspects of the study were of interest in looking critically at obese patients. Since Cushing's disease is often suspected in extremely obese patients, especially if they are a little hirsute or have pink striae, adrenal function studies were done on the group. Schultz, Kerlow, and Ulstrom'3 have reported a marked elevation of morning and evening plasma 17-hydroxycorticoids measured as PorterSilber chromogens after 13 days of fasting. Isotope-chromatographic measurements in two of their subjects failed to show increased hydrocortisone concentrations. The Porter-Silber chromogens measured after fasting were not further identified; but it seemed clear that hydrocortisone did not account for the increased chromogen material.
In the present study none of the six patients in whom the determination was done showed abnormally high plasma 1 1-hydroxycorticoids after seven days of fasting. In four, the values were actually lower than baseline levels and in two, although mildly elevated as compared with prefasting levels, were still in the normal range.
These findings are slightly different from those reported by Neuwirth, Philip, and Bondy in three normal subjects." Plasma cortisol, measured by a chromatographic technique, rose in all three of their volunteers and one patient reached a markedly elevated level at the end of the fast. These subjects fasted while performing their usual activities and may have been more stressed by the experimental conditions than our eight comfortable, bed-resting patients on the research unit.
Reduction of 17-KS excretion after fasting has been reported in lean men"' and in obese women.""8 Our results confirm these latter findings.
Whether this reduction represents a diminshed adrenal cortical function or alternate metabolic pathways of steroid metabolism is unknown. Urinary 17-OHCS excretion decreased after starvation in eight of nine patients tested both before and after fasting by Schultz, et al.'8 (Peterson's modification of the Porter and Silber method). Van Riet, et al.' found a uniform decrease in the urinary 17-OHCS of their starved subjects. In the present study three of the seven patients tested at the end of the fast had a slight increase in 17-KG steroids, but none of the values exceeded normal limits for our laboratory. The rise in patient S.G. from 3.6 to 4.2 mg/24 hours seemed insignificant. Both the other patients (C.G. and E.B.) had features suggesting endocrinopathy and we wondered whether their 17-KG steroid excretion response to fasting might differentiate them from the other patients. However, the rise was so modest we were unable to interpret it further.
The hyperuricemia of fasting did not result in any episodes of gout in the group studied, but this complication has been reported in other starvation studies.'7 Padova and Bendersky" have documented hyperuricemia in diabetic ketoacidosis with decreasing uric acid levels as the acetonemia and acetonuria diminished. Hyperuricemia occurred in 50 per cent of the patients studied even though they subsequently had normal uric acid values when the diabetes was under control. High-fat diets have been known to cause hyperuricemia since the studies of Cathcart in 1909," Lennox in 1925,' Harding, et al. in 1925," and Adlersberg, et al. in 1939.' During starvation the human body is on an endogenous high-fat diet and it is not surprising that the old observations are again being confirmed. In the past several years, therapeutic fasting in massive obesity has led to additional studies of hyperuricemia. Murphy and Shipman' have shown the mechanism to be a decrease in the renal clearance of uric acid, a reduction in glomerular filtration rate and an alteration in the renal tubular transport of uric acid. Hyperuricemia appeared before ketonemia and ketonuria were detected. Scott, McCallum, and Holloway" compared the effects of fasting, high-fat diets and infusions of sodium Beta-hydroxybutyrate on uric acid excretion. Their experiments confirmed that starvation and a high-fat diet cause impairment of uric acid excretion and a rise in serum uric acid. Infusions with Beta-hyroxybutyrate resulted in ketosis and a fall in urine uric acid. These authors suggest the mechanism to be an inhibition of uric acid excretion by ketone bodies and felt the acidosis is irrelevant since their infusions of Beta-hydroxybutyrate were given as alkaline solutions; the urine became alkaline and the total plasma carbon dioxide content rose. Our data agree with the conclusions of Murphy and Shipman' and of Scott, et al. ' Gamble, Ross, and Tisdall' studied several fasting epileptic children in 1923, and reported in meticulous detail the metabolism of "fixed base." They described an 8-year-old girl who fasted for 15 days and was then refed for three days on a light carbohydrate diet. Although food intake during refeeding was far short of the energy requirement, the child gained 0.7 kilogram. During the fast, intracellular and extracellular -water lost accounted for 62% of the body weight lost. On refeeding with carbohydrate, fixed base almost completely disappeared from the urine. Enough sodium was retained to maintain the normal base concentrations as body water was repleted.
Bloom' more recently has demonstrated that sodium excretion in the urine of fasting patients drops to low levels immediately after carbohydrate ingestion. He refed fasting patients with a 600 calorie carbohydrate diet and found that when normal salt intake was permitted the patient gained weight and when 200 mg. of sodium was given weight loss was abolished and the same salt retention was produced. In a later study, Gersing and Bloom' investigated the possibility that aldosterone might be the means by which glucose inhibited sodium excretion. They were able to increase the saluresis of fasting by spironolactone but glucose administration still blocked saluresis despite continued administration of spironolactone.
In our patients who had fasted, refeeding reduced sodium excretion to negligible levels whether the patient was refed on 500 calories of carbohydrate, 500 calories of protein, or 500 calories of balanced fat, protein, and carbohydrate. None of the patients in this group was given spironolactone or chlorthiazide. If sodium was not restricted in the refeeding period, a weight gain occurred (M.A.)
The mechanism of the phenomenon of almost complete retention of urinary sodium to maintain normal base concentrations in refeeding after fasting is unexplained at this time.
It was not possible to induce a saluresis by ammonium chloride loading and the reestablishment of acidosis comparable to that produced by fasting. Doses of triiodothyronine as large as 400 mg/day also had no effect on sodium excretion.
We were surprised that our one patient refed with protein had the same failure to excrete sodium as the carbohydrate-refed subjects. Additional patients are now being studied to gain more information regarding sodium balance in refeeding after starvation. This data will be reported in a separate paper.
Studies such as this one and others reported in the literature explore the usefulness of starvation as a therapeutic measure. All of the patients except one in this group tolerated starvation without hunger or real discomfort. The eighth patient, however, was depressed, weepy, and hungry. After fasting there is a moderately severe "rebound depression" since weight loss may slow or cease during refeeding. This discouraging period has not been commented upon in other starvation studies, but we found it a significant problem in our group, necessitating daily reassurance and psychotherapy. Hunger is not a problem in this phase, and our patients also encountered the increased satiety response after the consumption of very little food reported by Hollifield, et al. ' In patients with no medical contraindications such as gouty nephritis, very labile diabetes, or severe vascular disease, starvation may be a relatively easy way to initiate a weight reduction program. However, in a two-year follow up, these patients had not maintained their weight loss as well as patients treated more conventionally. In long-term treatment programs, repeated intermittent fasts as described by Duncane0 may be more successful than a single initial fast.
SUMMARY
Eight massively obese patients were studied during a baseline period, a 7-day fast and six days of refeeding. Although four of the patients had features suggesting endocrinopathy, their response to fasting was not significantly different from that of four generally obese patients. The fast was well tolerated by all the subjects. Metabolic acidosis and hyperuricemia occurred during fasting but cleared within 48 hours of refeeding.
Fasting plasma 1 1-hydroxycorticoid levels were normal both before and after starvation. The 17-KS values were all below baseline levels by the end of the fast, but three of the patients had a slight increase in 17-KG steroids with fasting.
During the refeeding period, sodium retention was noted regardless of whether the patients were refed with a diet balanced in carbohydrate, protein, and fat, or limited to carbohydrate or to protein. Weight gain occurred in one patient on a 500 calorie diet in whom sodium was not restricted. Weight loss in the other patients during refeeding varied from 0.25 to 5 pounds in six days. Daily plotting of weight curves did not reveal a true plateau.
It was concluded that fasting is not a useful procedure for improving the classification of obese patients. Although there were no untoward side effects during the study, patients often became severely depressed during the refeeding period. A two-year follow up did not indicate that the starved patients had been more successful in losing weight than others treated more conventionally.
